Printed from https://ideas.repec.org/s/spr/drugsa7.html
Content
August 2016, Volume 39, Issue 8
- 755-762 Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
by Megan E. B. Clowse & Steven R. Feldman & John D. Isaacs & Alexandra B. Kimball & Vibeke Strand & Richard B. Warren & Daniel Xibillé & Yan Chen & Donald Frazier & Jamie Geier & James Proulx & Amy Marren - 763-768 Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment
by Mulugeta Russom & Dawit Tesfai & Semere Gebregiorgis & Abdulmumini Usman & Selam Mihreteab & Iyassu Bahta & Elsa Mekonnen & Selamawit Ghebrehiwet & Gelila Abrham - 769-776 The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
by Leàn Rolfes & Florence Hunsel & Katja Taxis & Eugène Puijenbroek - 777-778 Is Earlier Signal Detection Always Better?
by Alan M. Hochberg & Stella Stergiopoulos
July 2016, Volume 39, Issue 7
- 589-611 Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
by Elise J. Smolders & Clara T. M. M. Kanter & Bart Hoek & Joop E. Arends & Joost P. H. Drenth & David M. Burger - 613-626 Neurocognitive Adverse Effects of Anesthesia in Adults and Children: Gaps in Knowledge
by Christopher G. Ward & Roderic G. Eckenhoff - 627-645 Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence
by Julia M. A. Sinclair & Sophia E. Chambers & Celia J. Shiles & David S. Baldwin
June 2016, Volume 39, Issue 6
- 491-500 Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention
by Thomas Goedecke & Kathryn Ord & Victoria Newbould & Sabine Brosch & Peter Arlett - 501-508 Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update
by Maria Gabriella Matera & Paola Rogliani & Luigino Calzetta & Mario Cazzola - 509-516 The Safety of Prochlorperazine in Children: A Systematic Review and Meta-Analysis
by Melissa Lau Moon Lin & Paula D. Robinson & Jacqueline Flank & Lillian Sung & L. Lee Dupuis
May 2016, Volume 39, Issue 5
- 371-373 Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?
by Jim Slattery - 375-380 Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients
by Sheriza N. Baksh & Walid F. Gellad & G. Caleb Alexander - 381-399 Side Effects and Efficacy of Neuraxial Opioids in Pregnant Patients at Delivery: A Comprehensive Review
by Sarah Armstrong & Roshan Fernando - 401-407 Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases
by Annamaria Mascolo & Concetta Rafaniello & Liberata Sportiello & Maurizio Sessa & Daniela Cimmaruta & Francesco Rossi & Annalisa Capuano - 409-419 Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants
by Haixia Li & Cailian Wang & Shuo Zhang & Sihao Sun & Ruifei Li & Meijuan Zou & Gang Cheng - 421-432 Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP)
by Manfred Hauben & Jeffrey K. Aronson & Robin E. Ferner - 433-441 An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
by Tal Lorberbaum & Kevin J. Sampson & Raymond L. Woosley & Robert S. Kass & Nicholas P. Tatonetti - 443-454 Social Media Listening for Routine Post-Marketing Safety Surveillance
by Gregory E. Powell & Harry A. Seifert & Tjark Reblin & Phil J. Burstein & James Blowers & J. Alan Menius & Jeffery L. Painter & Michele Thomas & Carrie E. Pierce & Harold W. Rodriguez & John S. Brownstein & Clark C. Freifeld & Heidi G. Bell & Nabarun Dasgupta - 455-464 Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®
by Jitka Pokladnikova & Ronald H. B. Meyboom & Ricarda Meincke & David Niedrig & Stefan Russmann - 465-466 Comment on: “Drug-Induced Hyperglycaemia and Diabetes”
by Jean-Louis Montastruc & Leila Chebane & Haleh Bagheri - 467-467 Authors’ Reply to Montastruc et al.: “Drug-Induced Hyperglycaemia and Diabetes”
by Neila Fathallah & Raoudha Slim & Sofiene Larif & Houssem Hmouda & Chaker Ben Salem
April 2016, Volume 39, Issue 4
- 277-280 Vulnerable Patients and Potential Harms: The Contribution of Observational Research
by Deborah Layton - 281-285 Pharmacovigilance is … Vigilance
by I. Ralph Edwards & Rachida Soulayamani Bencheikh - 287-294 Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension
by Caroline O’Connell & David Amar & Athénaïs Boucly & Laurent Savale & Xavier Jaïs & Marie-Camille Chaumais & David Montani & Marc Humbert & Gérald Simonneau & Olivier Sitbon - 295-305 Quantitative Risk–Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease
by William E. Bennett - 307-321 Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink
by Marlene Bloechliger & Alessandro Ceschi & Stephan Rüegg & Hugo Kupferschmidt & Stephan Kraehenbuehl & Susan S. Jick & Christoph R. Meier & Michael Bodmer - 323-333 Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
by Rhian McNaughton & Elizabeth Lynn & Vicki Osborne & Abigail Coughtrie & Deborah Layton & Saad Shakir - 335-345 Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®
by Haggar H. Ampadu & Jarno Hoekman & Marieke L. Bruin & Shanthi N. Pal & Sten Olsson & Daniele Sartori & Hubert G. M. Leufkens & Alexander N. O. Dodoo - 347-354 Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database
by Izyan A. Wahab & Nicole L. Pratt & Lisa Kalisch Ellett & Elizabeth E. Roughead - 355-364 Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases
by Suzie Seabroke & Gianmario Candore & Kristina Juhlin & Naashika Quarcoo & Antoni Wisniewski & Ramin Arani & Jeffery Painter & Philip Tregunno & G. Niklas Norén & Jim Slattery - 365-365 Comment on ‘The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project’
by Alain Braillon - 367-368 Authors’ Reply to Alain Braillon’s Comment on “The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project”
by Emanuel Raschi & Elisabetta Poluzzi & Francesco Salvo & Ugo Moretti & Fabrizio Ponti - 369-369 Erratum to: Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
by Rose I. Okonkwo & Anita E. Weidmann & Emmanuel E. Effa
March 2016, Volume 39, Issue 3
- 193-197 Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions
by Hamed Khalili - 199-208 Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
by Joshua B. French & Maurizio Bonacini & Marwan Ghabril & David Foureau & Herbert L. Bonkovsky - 209-218 Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
by Rose I. Okonkwo & Anita E. Weidmann & Emmanuel E. Effa - 219-230 Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis
by Edouard Ledent & Alfons Lieftucht & Hubert Buyse & Keiji Sugiyama & Michael Mckenna & Katsiaryna Holl - 231-240 Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter
by Abeed Sarker & Karen O’Connor & Rachel Ginn & Matthew Scotch & Karen Smith & Dan Malone & Graciela Gonzalez - 241-250 Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin
by Maxim Topaz & Kenneth Lai & Neil Dhopeshwarkar & Diane L. Seger & Roee Sa’adon & Foster Goss & Ronen Rozenblum & Li Zhou - 251-260 A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases
by Mickael Arnaud & Francesco Salvo & Ismaïl Ahmed & Philip Robinson & Nicholas Moore & Bernard Bégaud & Pascale Tubert-Bitter & Antoine Pariente - 261-270 Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology
by Christian Hampp & Patty Greene & Simone P. Pinheiro - 271-276 The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015
by Roni P. Dodiuk-Gad & Cristina Olteanu & Wen-Hung Chung & Neil H. Shear
February 2016, Volume 39, Issue 2
- 93-107 Mortality Risk of Hypnotics: Strengths and Limits of Evidence
by Daniel F. Kripke - 109-116 Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
by Cathal A. Cadogan & Cristín Ryan & Carmel M. Hughes - 117-130 Testosterone Replacement Therapy and Mortality in Older Men
by G. I. Hackett - 131-146 Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review
by Thi-Ha Vo & Bruno Charpiat & Claire Catoire & Michel Juste & Renaud Roubille & François-Xavier Rose & Sébastien Chanoine & Jean-Luc Bosson & Ornella Conort & Benoît Allenet & Pierrick Bedouch - 147-157 Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
by Michael W. Dunne & George H. Talbot & Helen W. Boucher & Mark Wilcox & Sailaja Puttagunta - 159-169 Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports
by Christine Njuguna & Annemie Stewart & Johannes P. Mouton & Marc Blockman & Gary Maartens & Annoesjka Swart & Briony Chisholm & Jackie Jones & Mukesh Dheda & Ehimario U. Igumbor & Karen Cohen - 171-184 Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial
by Lauren McCormack & R. Craig Lefebvre & Carla Bann & Olivia Taylor & Paula Rausch - 185-192 Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
by Kevin Klein & Joep H. G. Scholl & Niels S. Vermeer & André W. Broekmans & Eugène P. Puijenbroek & Marie L. Bruin & Pieter Stolk
January 2016, Volume 39, Issue 1
- 1-3 What Is the Plural of a ‘Yellow’ Anecdote?
by Stephen J. W. Evans - 5-13 Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives
by Steen Husted & Freek W. A. Verheugt & Willemijn J. Comuth - 15-27 Advances in the Pharmacogenomics of Adverse Drug Reactions
by Susannah L. Collins & Daniel F. Carr & Munir Pirmohamed - 29-43 An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies
by Miguel-Angel Maciá-Martínez & Francisco J. Abajo & Gilly Roberts & Jim Slattery & Bharat Thakrar & Antoni F. Z. Wisniewski - 45-57 Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
by Juan M. Banda & Alison Callahan & Rainer Winnenburg & Howard R. Strasberg & Aurel Cami & Ben Y. Reis & Santiago Vilar & George Hripcsak & Michel Dumontier & Nigam Haresh Shah - 59-68 The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project
by Emanuel Raschi & Elisabetta Poluzzi & Francesco Salvo & Ariola Koci & Marc Suling & Stefania Antoniazzi & Luisella Perina & Lorna Hazell & Ugo Moretti & Miriam Sturkenboom & Edeltraut Garbe & Antoine Pariente & Fabrizio Ponti - 69-78 Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®
by Ana Aldea Perona & Mar García-Sáiz & Emilio Sanz Álvarez - 79-87 The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study
by C. A. K. Stelt & A. M. A. Vermeulen Windsant-van den Tweel & A. C. G. Egberts & P. M. L. A. Bemt & A. J. Leendertse & W. A. J. J. Hermens & R. J. Marum & H. J. Derijks - 89-90 Comment on: “Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case–Control Study in Haryana, India”
by Sibel Yöntem & Belgin Maden-Tastan & Yusuf Cem Kaplan - 91-92 Authors’ Reply to Sibel Yöntem and Colleagues’ Comment on “Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India”
by Sutapa Bandyopadhyay Neogi & Preeti H. Negandhi & Ravi Kant Gupta & Abhijit Ganguli & Sanjay Zodpey & Amarjeet Singh & Rakesh Gupta
July 2015, Volume 38, Issue 7
- 611-620 DNA Barcoding and Pharmacovigilance of Herbal Medicines
by Hugo J. Boer & Mihael C. Ichim & Steven G. Newmaster
October 2014, Volume 37, Issue 10
- 743-759 Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
by Jürgen Beckmann & Ulrich Hagemann & Priya Bahri & Andrew Bate & Ian Boyd & Gerald Dal Pan & Brian Edwards & I. Edwards & Kenneth Hartigan-Go & Marie Lindquist & John McEwen & Yola Moride & Sten Olsson & Shanthi Pal & Rachida Soulaymani-Bencheikh & Marco Tuccori & Claudia Vaca & Ian Wong - 761-764 Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet
by G. Norén - 765-770 Pharmacovigilance in China: Current Situation, Successes and Challenges
by Li Zhang & Lisa Wong & Ying He & Ian Wong - 771-776 Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies
by Joshua Gagne - 777-790 Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art
by Rave Harpaz & Alison Callahan & Suzanne Tamang & Yen Low & David Odgers & Sam Finlayson & Kenneth Jung & Paea LePendu & Nigam Shah - 791-804 The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis
by Jacqueline Flank & Lillian Sung & Christopher Dvorak & Wendy Spettigue & L. Dupuis - 805-813 Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK
by Pernille Warrer & Lise Aagaard & Ebba Hansen - 815-829 Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events
by Agata Ptaszynska & Kristina Johnsson & Shamik Parikh & Tjerk Bruin & Anne Apanovitch & James List
September 2012, Volume 35, Issue 9
- 695-709 Early Investigation of QTc Liability
by Rashmi R. Shah & Joel Morganroth - 711-724 A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
by Victor A. Kiri - 725-731 A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization
by Andrew J. Muzyk & Sarah K. Rivelli & Wei Jiang & Heather Heinz & Amber Rayfield & Jane P. Gagliardi - 733-743 Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records
by Andrew Tomlin & David Reith & Susan Dovey & Murray Tilyard - 745-758 Drug Interactions in Dying Patients
by Sebastian Frechen & Anna Zoeller & Klaus Ruberg & Raymond Voltz & Jan Gaertner - 759-767 Drug Fever
by Dominique Vodovar & Christine LeBeller & Bruno Mégarbane & Agnes Lillo-Le-Louet & Thomas Hanslik - 769-781 Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
by Chen Wu & Chaim M. Bell & Walter P. Wodchis
December 2001, Volume 24, Issue 14
- 1019-1026 Technologies to Improve Immunisation Safety
by C. John Clements & Maria Teresa Aguado & Luis Jódar - 1027-1037 Benefits and Risks of Self Medication
by Carmel M. Hughes & James C. McElnay & Glenda F. Fleming - 1039-1053 Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention
by Michèle G. Curtis - 1055-1063 Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy
by Miriam B. Borden & Ann L. Parke - 1065-1080 Asthma Medications and their Potential Adverse Effects in the Elderly
by Donald Mackenzie Newnham - 1081-1090 Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide
by Anita Conforti & Roberto Leone & Ugo Moretti & Federico Mozzo & Giampaolo Velo